HealthTech Bio Actives S.L.U.

Based in Spain, HealthTech Bio Actives S. L. U. focuses on producing high-quality citrus flavonoids and active forms of Vitamin B12, utilizing environmentally friendly extraction methods to meet the growing demand for natural health products.

HealthTech Bio Actives S. L. U. engages in the production of specialized bioactive ingredients.

The firm was founded in 1978 and is headquartered in Barcelona, Spain. The company has completed 2 deals, with its most recent deal occurring on November 5, 2024, when Miura Partners acquired HealthTech for EUR 250 million, marking a strategic pivot in its business operations. The total amount raised by the company amounts to EUR 250 million. The CEO of HealthTech is Alexandre Valls-Coma, who leads the company in expanding its market presence.

HealthTech Bio Actives S. L. U. specializes in the production of high-quality citrus flavonoids and active forms of Vitamin B12.

The company employs green extraction processes to ensure its products are environmentally friendly, catering to customer demands for natural and effective ingredients. Their primary offerings are utilized across various segments, including pharmaceuticals, functional health, taste modulation, and animal nutrition. HealthTech markets its products primarily in North America, Europe, and parts of Asia, addressing the global demand for natural health solutions. In the most recent year, HealthTech Bio Actives reported a revenue of EUR 64,523,491.

30 and an EBITDA of EUR 13,090,726. 90. The company generates revenue through direct partnerships with businesses in the health and wellness sectors, focusing on B2B transactions. Clients include wholesalers, retailers, and formulators engaging in bulk purchases of core products, establishing long-term contracts that often include service agreements for ongoing technical support and product development assistance.

Following the acquisition by Miura Partners on November 5, 2024, HealthTech Bio Actives plans to improve its business offerings and expand its market presence. The company is focused on launching new products in the upcoming year and is exploring entry into new markets, specifically targeting additional regions in Asia and Eastern Europe by 2025. The recent funding will be allocated to enhance product development and expand marketing efforts to support these initiatives.